Vontobel Holding
VTVT icon

Vontobel Holding’s vTv Therapeutics VTVT Stock Holding History

Vontobel Holding’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$123K – 1215
2021
Q3 		$123K Hold
2,000
– – ﹤0.01% 1082
2021
Q2 		$182K Hold
2,000
– – ﹤0.01% 1042
2021
Q1 		$226K Buy
2,000
+875
+78% +$86K ﹤0.01% 888
2020
Q4 		$84K Buy
+1,125
New +$86.3K ﹤0.01% 938

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vontobel Holding's VTVT Position: Q4 2021 in Review

Vontobel Holding sold out of vTv Therapeutics (VTVT) in Q4 2021, closing a stake of 2,000 shares — an estimated $123K sold.

Vontobel Holding first reported a position in VTVT in Q4 2020 and held it in 4 quarters. The position peaked at $226K in Q1 2021. 29 funds tracked by Wall St. Rank hold VTVT as of Q4 2021.

  • Vontobel Holding reported no remaining vTv Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Vontobel Holding sold 2,000 vTv Therapeutics shares in Q4 2021, an estimated $123K.
  • Vontobel Holding first reported a position in vTv Therapeutics in Q4 2020 and held it in 4 quarters.
  • Vontobel Holding's vTv Therapeutics position peaked at $226K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.